GUGGENHEIM CAPITAL LLC - MADRIGAL PHARMACEUTICALS INC ownership

MADRIGAL PHARMACEUTICALS INC's ticker is MDGL and the CUSIP is 558868105. A total of 139 filers reported holding MADRIGAL PHARMACEUTICALS INC in Q1 2019. The put-call ratio across all filers is 0.45 and the average weighting 0.2%.

Quarter-by-quarter ownership
GUGGENHEIM CAPITAL LLC ownership history of MADRIGAL PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$458,127
-26.7%
3,137
+15.9%
0.00%
-20.0%
Q2 2023$625,086
-17.7%
2,706
-13.7%
0.01%
-16.7%
Q1 2023$759,970
-45.1%
3,137
-80.5%
0.01%
-45.5%
Q3 2019$1,385,000
-22.8%
16,064
-6.1%
0.01%
-26.7%
Q2 2019$1,793,000
-11.5%
17,107
+5.7%
0.02%
-11.8%
Q1 2019$2,027,000
+1.0%
16,181
-9.1%
0.02%0.0%
Q4 2018$2,007,00017,8030.02%
Other shareholders
MADRIGAL PHARMACEUTICALS INC shareholders Q1 2019
NameSharesValueWeighting ↓
HealthCor Management, L.P. 1,402,250$93,614,0004.00%
Parkman Healthcare Partners LLC 30,000$2,003,0000.93%
ARMISTICE CAPITAL, LLC 216,000$14,420,0000.89%
Avoro Capital Advisors LLC 349,000$23,299,0000.79%
Rock Springs Capital Management LP 250,000$16,690,0000.69%
Capital Impact Advisors, LLC 24,351$1,626,0000.68%
Baker Brothers Advisors 1,499,212$100,087,0000.62%
EWG Elevate Inc. 11,086$740,0000.56%
SHIKIAR ASSET MANAGEMENT INC 12,000$801,0000.54%
DAFNA Capital Management LLC 13,600$908,0000.38%
View complete list of MADRIGAL PHARMACEUTICALS INC shareholders